Weijun Xu

15PUBLICATIONS
34CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsMedical biochemistry - proteins and peptides (incl. medical proteomics)Biomolecular modelling and designBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 26, 2026
In Silico-Enabled Discovery and Development of Potent and Selective CDK11 Inhibitors.

Frankie S Mak, Fui Mee Ng, Padmanabhan Anbazhagan

|Aug 07, 2025
Discovery of an Orally Bioavailable Reversible Covalent SARS-CoV-2 Mpro Inhibitor with Pan-Coronavirus Activity.

Qian Wen Tan, Subramanyam Vankadara, Jia Yi Fong

|Apr 24, 2025
Structure-based discovery of novel non-covalent small molecule inhibitors of USP30.

Padmanabhan Anbazhagan, Jothi Anantharajan, Justina Fulwood

|Feb 24, 2025
Fragment-Based Drug Design: From Then until Now, and Toward the Future.

Weijun Xu, Congbao Kang

|Jan 24, 2025
Leveraging Structural and Computational Biology for Molecular Glue Discovery.

Congbao Kang, Weijun Xu

|Jan 17, 2025
Cigarette smoke components modulate the MR1-MAIT axis.

Wael Awad, Jemma R Mayall, Weijun Xu

Pageof 3

Frequent Collaborators

7 joint publications

Congbao Kang

3 joint publications

Pearly Shuyi Ng

2 joint publications

David E Heppner

2 joint publications

C S Brian Chia